The Rapid Naming Test: Development and initial validation in typically aging adults.
The Rapid Naming Test: Development and initial validation in typically aging adults.
复制标题
DOI:
10.1080/13854046.2021.1900399
复制
发表时间:
2022-10
期刊:
影响因子:
--
通讯作者:
Kramer JH
中科院分区:
文献类型:
--
作者:
Stiver J;Staffaroni AM;Walters SM;You MY;Casaletto KB;Erlhoff SJ;Possin KL;Lukic S;La Joie R;Rabinovici GD;Zimmerman ME;Gorno-Tempini ML;Kramer JH
Progressive word-finding difficulty is a primary cognitive complaint among healthy older adults and a symptom of pathological aging. Classic measures of visual confrontation naming, however, show ceiling effects among healthy older adults. To address the need for a naming test that is sensitive to subtle, age-related word-finding decline, we developed the Rapid Naming Test (RNT), a computerized, one-minute, speeded visual naming test. Functionally intact older (n=145) and younger (n=69) adults completed the RNT. Subsets of older adults also completed neuropsychological tests, a self-report scale of functional decline, amyloid-β PET imaging, and repeat RNT administration to determine test-retest reliability. RNT scores were normally distributed and exhibited good test-retest reliability. Younger adults performed better than older adults. Within older adults, lower scores were associated with older age. Higher scores correlated with measures of language, processing speed, and episodic learning and memory. Scores were not correlated with visuospatial or working memory tests. Worse performance was related to subjective language decline, even after controlling for a classic naming test and speed. The RNT was also negatively associated with amyloid-β burden. The RNT appears to be a reliable test that is sensitive to subtle, age-related word-finding decline. Convergent and divergent validity are supported by its specific associations with measures relying on visual naming processes. Ecological validity is supported by its relationship with subjective real-world language difficulties. Lastly, worse performance was related to amyloid-β deposition, an Alzheimer’s disease biomarker. This study represents a key step toward validating a novel, sensitive naming test in typically aging adults.
登录
查看更多内容
影响因子:
2.4
作者:
Heflin, Lara H.;Laluz, Victor;Jang, Jung;Ketelle, Robin;Miller, Bruce L.;Kramer, Joel H.
通讯作者:
Kramer, Joel H.
影响因子:
8.2
作者:
Hartshorne JK;Germine LT
通讯作者:
Germine LT
影响因子:
3.7
作者:
Brodeur MB;Dionne-Dostie E;Montreuil T;Lepage M
通讯作者:
Lepage M
影响因子:
4
作者:
Facal, David;Juncos-Rabadan, Onesimo;Pereiro, Arturo X.
通讯作者:
Pereiro, Arturo X.
影响因子:
3.7
作者:
Brodeur MB;Guérard K;Bouras M
通讯作者:
Bouras M